Scarica l'app Stockscreener
9.03
0.58%
-0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cogent Biosciences Inc Borsa (COGT) Ultime notizie
Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $21.00 at JPMorgan Chase & Co. - Defense World
FY2024 EPS Forecast for Cogent Biosciences Lifted by Analyst - MarketBeat
Trend Tracker for (COGT) - Stock Traders Daily
Cogent Biosciences (NASDAQ:COGT) Shares Down 7%Should You Sell? - MarketBeat
Lifesci Capital Has Negative Outlook of COGT FY2024 Earnings - Defense World
Equities Analysts Offer Predictions for COGT FY2024 Earnings - Defense World
Leerink Partnrs Has Strong Forecast for COGT FY2027 Earnings - MarketBeat
Wedbush Research Analysts Lower Earnings Estimates for COGT - MarketBeat
FY2024 Earnings Estimate for COGT Issued By Lifesci Capital - MarketBeat
COMMODORE CAPITAL LP's Strategic Acquisition in Cogent Biosciences Inc - GuruFocus.com
Wedbush Reaffirms “Neutral” Rating for Cogent Biosciences (NASDAQ:COGT) - Defense World
Cogent Biosciences (NASDAQ:COGT) Announces Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Needham & Company LLC Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - MarketBeat
Cogent Biosciences Inc (COGT) Quarterly 10-Q Report - Quartz
Cogent Biosciences Reports Progress in Clinical Trials and Financial Standing - TipRanks
Cogent Biosciences Inc Reports Q3 2024 Net Loss Per Share of $0. - GuruFocus.com
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results - GlobeNewswire
Cogent Biosciences Reports Strong Pipeline Progress, $346M Cash Position Despite Q3 Losses | COGT Stock News - StockTitan
Creative Planning Buys 3,272 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences’ (COGT) Buy Rating Reaffirmed at HC Wainwright - Defense World
FMR LLC Acquires Additional Shares in Cogent Biosciences Inc - GuruFocus.com
(COGT) Trading Advice - Stock Traders Daily
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.3%Here's What Happened - MarketBeat
Cogent Biosciences Announces Bezuclastinib Presentations at - GlobeNewswire
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting - The Manila Times
Cogent Biosciences to Present Key Bezuclastinib Trial Data at ASH 2024 Meeting | COGT Stock News - StockTitan
Cogent Biosciences' (COGT) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.67 Average PT from Brokerages - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
(COGT) Investment Analysis - Stock Traders Daily
Hennion & Walsh Asset Management Inc. Purchases 44,287 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences' (COGT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Cogent Biosciences expands pipeline with KRAS inhibitor - Investing.com
Cogent Biosciences expands pipeline with KRAS inhibitor By Investing.com - Investing.com UK
Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics - StockTitan
Cogent Biosciences Announces Pipeline Expansion into KRAS - GlobeNewswire
COGT Stock Hits 52-Week High at $12.2 Amid Market Optimism - Investing.com India
Cogent Biosciences (NASDAQ:COGT) Sets New 52-Week HighHere's What Happened - MarketBeat
Here's Why We're Not Too Worried About Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation - Yahoo Finance
SG Americas Securities LLC Acquires New Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
The Manufacturers Life Insurance Company Has $301,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Market Momentum Report: Cogent Biosciences Inc (COGT)’s Negative Close at 11.35 - The Dwinnex
Cogent Biosciences (NASDAQ:COGT) Shares Down 2.4%What's Next? - MarketBeat
(COGT) Technical Data - Stock Traders Daily
Stocks of Cogent Biosciences Inc (COGT) are poised to climb above their peers - SETE News
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.6%Here's What Happened - MarketBeat
Did Cogent Biosciences Inc (COGT) perform well in the last session? - US Post News
Analysts Rate Cogent Biosciences, Inc. (COGT) as Moderate Buy with $15 Target - Insider Monkey
Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - SETE News
Metric Deep Dive: Understanding Cogent Biosciences Inc (COGT) Through its Ratios - The Dwinnex
Dimensional Fund Advisors LP Has $7.84 Million Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
(COGT) On The My Stocks Page - Stock Traders Daily
American Century Companies Inc. Sells 7,032 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Algert Global LLC - Defense World
Algert Global LLC Sells 207,078 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2% - MarketBeat
A better buy-in window may exist right now for Cogent Biosciences Inc (COGT) - SETE News
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):